• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 18 Mar 2025

SBIO: Increasing Target Price on Strong Q4 & 2024 Financials


Sabio Holdings, Inc. (SBIO:TSX) | 0 0 0.0%


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 5 pages


 

What you need to know: • Sabio reported excellent Q4 and 2024 financial results that beat our original expectations prior to being revised upward on the pre-release. • Revenue came in at $18.3M (+44% YoY) compared to our original estimate of $16.4M and revised estimate of $18.0M. Adjusted EBITDA came in at $2.8M (+38% YoY) vs. our estimate of $2.7M. • Sabio guided for continued solid growth and margins into 2025 and 2026. • We recently published an interview with management, watch it here. Yesterday after market close, Sabio Holdings Inc. (SBIO:TSXV, SABOF:OTC) reported stellar Q4 and 2024 financial results, exhibiting 44% revenue growth and 38% EBITDA growth in the quarter. Q4 was driven by continued rapid growth in the ad-supported streaming segment while the mobile segment returned to positive growth for a 2nd consecutive quarter. We recently published a management interview with CEO Aziz Rahimtoola and CFO Sajid Premji, watch it here. We are maintaining our BUY rating and increasing our target price to C$1.00/share (previously C$0.90/share) on Sabio Holdings. Q4/24 Highlights • Revenue of $18.3M (+44% YoY), beating our revised estimate of $18.0M (originally $16.4M) and slightly exceeding management’s guidance of between $18.0-18.2M. The strong growth was led by ad-supported streaming segment which grew 57% YoY and represented 79% of sales. Normalizing for political revenue, the ad-supported streaming revenue grew 32% in the quarter. The mobile segment grew 16% YoY, its 2nd consecutive quarter of growth. • Gross margin of 62% beating our revised estimates of 60% (originally 62%) and management’s guidance of 59% to 61%. • Adjusted EBITDA of $2.8M (16% margin, +38% YoY growth) beating our estimate of $2.7M and hitting the top end of management’s guidance of between $2.6M and $2.8M. This was led by SBIO’s improved cost structure. • Net income of $1.2M vs. our estimates of $2.0M. The miss was attributable to a $0.9M loss on loan forgiveness. • Sabio ended the quarter with $3.3M in cash vs. $2.9M in Q3/24 and $6.8M in total debt compared to $7.2M in Q3/24.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

SBIO: Increasing Target Price on Strong Q4 & 2024 Financials


Sabio Holdings, Inc. (SBIO:TSX) | 0 0 0.0%


  • Published: 18 Mar 2025
  • Author: Nicholas Cortellucci, CFA
  • Pages: 5
  • Atrium Research


What you need to know: • Sabio reported excellent Q4 and 2024 financial results that beat our original expectations prior to being revised upward on the pre-release. • Revenue came in at $18.3M (+44% YoY) compared to our original estimate of $16.4M and revised estimate of $18.0M. Adjusted EBITDA came in at $2.8M (+38% YoY) vs. our estimate of $2.7M. • Sabio guided for continued solid growth and margins into 2025 and 2026. • We recently published an interview with management, watch it here. Yesterday after market close, Sabio Holdings Inc. (SBIO:TSXV, SABOF:OTC) reported stellar Q4 and 2024 financial results, exhibiting 44% revenue growth and 38% EBITDA growth in the quarter. Q4 was driven by continued rapid growth in the ad-supported streaming segment while the mobile segment returned to positive growth for a 2nd consecutive quarter. We recently published a management interview with CEO Aziz Rahimtoola and CFO Sajid Premji, watch it here. We are maintaining our BUY rating and increasing our target price to C$1.00/share (previously C$0.90/share) on Sabio Holdings. Q4/24 Highlights • Revenue of $18.3M (+44% YoY), beating our revised estimate of $18.0M (originally $16.4M) and slightly exceeding management’s guidance of between $18.0-18.2M. The strong growth was led by ad-supported streaming segment which grew 57% YoY and represented 79% of sales. Normalizing for political revenue, the ad-supported streaming revenue grew 32% in the quarter. The mobile segment grew 16% YoY, its 2nd consecutive quarter of growth. • Gross margin of 62% beating our revised estimates of 60% (originally 62%) and management’s guidance of 59% to 61%. • Adjusted EBITDA of $2.8M (16% margin, +38% YoY growth) beating our estimate of $2.7M and hitting the top end of management’s guidance of between $2.6M and $2.8M. This was led by SBIO’s improved cost structure. • Net income of $1.2M vs. our estimates of $2.0M. The miss was attributable to a $0.9M loss on loan forgiveness. • Sabio ended the quarter with $3.3M in cash vs. $2.9M in Q3/24 and $6.8M in total debt compared to $7.2M in Q3/24.

More Content

More Content

SBIO: Weak Q3 Financials; Still Eyeing 2026

Companies: Sabio Holdings, Inc.

Atrium Research

SBIO: A Rising Ad-Tech Player in the Growing Streaming TV Market

Companies: Sabio Holdings, Inc.

Atrium Research

Q3/25 Recap: All Our Research in One Place!

Companies: NIM SPA CUU VAPE SCZ DRX AUAU ARG OMG BQE GEC CUU DNG EDG KRI KNR KRI MOO NIM RIO SPA SBIO LVG TM NFLD FRG NAMM SCZ CAPT GIGA MSA APM FISH

Atrium Research

SBIO: Preliminary Q4 Financials; Best Quarter in Company History

Companies: Sabio Holdings, Inc.

Atrium Research

Cantech Investment Conference: Research Booklet

Companies: XX XX BQE BYL BIGG TRBE DCM YFI ENW FTG HITI MGRO GRID TTGI SBIO WELL XTRAF ANRG CLA ENW AIDX

Atrium Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS - Research as a Service
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In